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Abstract: The prevalence and severity of depression differ in women and men and across racial
groups. Psychosocial factors such as chronic stress have been proposed as contributors, but causes
of this variation are not fully understood. Allostatic load, a measure of the physiological burden
of chronic stress, is known to be associated with depression. Using data from the National Health
and Nutrition Examination Survey 2005–2010, we examined the associations of nine allostatic load
biomarkers with depression among US black and white adults aged 18–64 years (n = 6431). Depressive
symptoms were assessed using the Patient Health Questionaire-9; logistic models estimated adjusted
odds of depression based on allostatic load biomarkers. High-risk levels of c-reactive protein were
significantly associated with increased odds of depression among white women (adjusted odds ratio
(aOR) = 1.7, 95% CI: 1.1–2.5) and men (aOR = 1.8, 95% CI: 1.1–2.8) but not black women (aOR = 0.8,
95% CI: 0.6–1.1) or men (aOR = 0.9, 95% CI: 0.5–1.5). Among black men, hypertension (aOR = 1.7,
95% CI: 1.1–2.7) and adverse serum albumin levels (aOR = 1.7, 95% CI: 1.0–2.9) predicted depression,
while high total cholesterol was associated with depression among black women (aOR = 1.6, 95% CI:
1.0–2.7). The associations between allostatic load biomarkers and depression varies with gendered
race, suggesting that, despite consistent symptomatology, underlying disease mechanisms may differ
between these groups.
Keywords: chronic stress; allostatic load; depression; gender; race; intersectionality
1. Introduction
A large proportion of the United States chronic disease burden is attributed to depressive
disorders [1]. Major depressive disorder (MDD), the most common form of depression, is the leading
cause of disability among those aged 15 years and older [2]. Of central public health concern are racial
and gender disparities in who develops depression; differences in the prevalence and incidence of
MDD diagnosis and depressive symptomatology between black and white women and men have
been well documented [3–6]. Specifically, rates of MDD diagnosis are higher among white persons.
Yet, black women and men report a higher prevalence of depressive symptoms. Further, there is
evidence that somatic symptoms are more common among black persons, while affective symptoms of
depression are more frequently reported among whites [7].
Consensus has yet to be reached on what proportion of this disparity can be attributed to true
differences in disease prevalence and manifestation between these groups as opposed to cultural
and social factors yielding underreporting, underdiagnosis, and undertreatment of depression in
black persons and men [8]. A host of genetic and social factors are thought to be associated with the
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likelihood of developing depression [4,9–14], further underscoring a need for additional investigation.
In concert with potential surveillance inconsistencies, persistent uncertainty about the mechanisms for
these risk factors [9] render efforts to characterize and alleviate true racial and gender disparities in
depression particularly challenging.
One approach to identifying mechanisms for an effect of social status on the development of
depression is the use of allostatic load, a measure of the physiological wear and tear accumulating
from sustained stress exposure. The concept of allostatic load within the epidemiological discipline has
improved efforts to evaluate the role of race and gender inequity in yielding depression disparities [10].
Social environment theories for gender differences in depression attribute much of the increased
risk for depression among women to chronic strain associated with the subordinate social position
women occupy [4,11,15]. A growing body of evidence supports a number of key physiological
measures as markers of chronic stress burden associated with psychosocial exposures stemming from
membership in a disadvantaged social group. Adverse levels of neuroendocrine, cardiovascular,
metabolic, and immunological biomarkers comprising AL have been linked to perception of social
rejection, marginalization, and exclusion [11,16–19]. Specifically, this research emphasizes the role
of inflammatory processes in mediating the effect of threatening social stimuli, such as identity
threat stemming from perceived racial or gender discrimination, on health [11,16]. As evidence for
depression as an inflammatory disease emerges [11,20,21], studies linking psychosocial risk factors
with inflammatory indicators of chronic stress offer biologically plausible mechanisms for depression
as a manifestation of the chronic stress associated with exposure to structural inequity.
“Paradoxical” findings of lower rates of MDD among black persons [22,23], who, like women,
occupy marginalized social positions [24], complicate social environment theories. The impact
of socioeconomic factors on depression varies between black and white communities [3], with
socioeconomic position largely accounting for gender disparities among black persons but not white.
More work is needed to understand these divergent findings in regard to the pathogenesis of depression
across these groups.
In efforts to account for gender–race differences in the relationship of chronic psychosocial stress
with depression, etiologic inquiry has increasingly turned to epigenetic explanations, centering the
interdependency of biological and social risk factors for disease [9]. Within such sociobiological
frameworks, further consideration of the psychosocial exposures individuals encounter at the junction
of gender and race (“gendered racial” exposures) becomes integral to clarifying the causes of persistent
differences in depression morbidity. Examined through the lens of intersectionality theory [25],
intersecting axes of structured inequity on the basis of gender and race impose a set of chronic
social stressors whose effects on health cannot be reasonably separated into individual racial and
gendered components. Acting concomitantly with biological vulnerability, these unique gendered
racial exposures may serve as catalysts for psychopathology among certain populations but not others,
as proposed by the differential effect hypothesis [26], in addition to shaping the way psychological
distress manifests within these groups. Research investigating the nature of social group variation in
the effects of chronic strain on mental health may therefore provide valuable insight into the causes
and magnitude of gendered racial differences in risk for depression and elucidate opportunities for
improvement in treatment efficacy.
Although previous literature has identified an association of inflammation with depression among
white but not black persons [27,28], to our knowledge no US study has examined the extent to which
gender and race simultaneously moderate the association of individual allostatic load components
with depression. To address this lacuna, this analysis uses a nationally representative sample to explore
variation in the relationships between nine allostatic load biomarkers of chronic stress and depressive
symptoms among black and white women and men.
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2. Materials and Methods
2.1. Data
We used data from the National Health and Nutrition Examination Survey (NHANES), 2005–2010.
These years were combined to maximize sample size; the analysis was limited to this time period
because a different depression measure was used prior to 2005 and all biomarkers of interest
were not included after 2010. Conducted by the National Center for Health Statistics (NCHS),
NHANES uses weighted samples to provide national estimates of health and nutritional status for the
noninstitutionalized population of the United States. Study staff use specially designed and equipped
mobile health centers that travel to locations throughout the country to take health measurements
on about 5000 participants in 15 counties annually. NHANES data collection methodology has been
further documented elsewhere [29].
2.2. Participants
Our analytic sample included men and women aged 18–64 years who self-identified as
non-Hispanic black or non-Hispanic white (referred to hereafter as “black” and “white”) from options
provided by investigators that included Mexican-American, Other Hispanic, Non-Hispanic White,
Non-Hispanic Black, and Other Race—including Multi-Racial. Pregnant women (n = 490) were
excluded, as pregnancy can alter a number of physiological measures comprising allostatic load [30,31].
Of the 14,050 participants aged 18–64 years in NHANES 2005–2010, we further excluded participants
whose reported race was not black or white (n = 5025), those missing information on any of the
questions included in the depression measure (n = 1824), AL biomarkers of interest (n = 2530), and/or
family poverty–income ratio (PIR, n = 1120).
2.3. Depressive Symptoms
Participants completed the 9-item Patient Health Questionnaire (PHQ), a validated screen for
depression [32]. Each question on this self-reported assessment of Diagnostic and Statistical Manual of
Mental Disorders 4th edition signs and symptoms of depression is scored from 0 (not at all) to 3 (nearly
every day), with a total possible score of 27 calculated by summing the scores of the nine individual
questions. A total score of ten or higher is considered indicative of major depression [32].
2.4. Allostatic Load Biomarkers
The biomarkers included in this analysis as comprising the allostatic load (AL) are consistent with
previous research [10,33,34]. These include three cardiovascular biomarkers (systolic and diastolic
blood pressure (BP), and pulse rate); four metabolic markers (glycosolated hemoglobin, body mass
index (BMI), high-density lipoprotein (HDL) cholesterol, and total cholesterol); and two immunological
markers (serum albumin and c-reactive protein (CRP)). Systolic and diastolic BP values were calculated
as the average of three readings. Biomarkers with values above the 75th percentile of nationally
weighted empirical cutoffs were categorized as “high-risk”, with the exception of serum albumin and
HDL cholesterol, which were categorized as “high-risk” for values below the 25th percentile empirical
cutoff, as lower values of these biomarkers are considered indicative of poor physiological function.
High-risk thresholds were as follows: systolic BP > 127.3 mmHG; diastolic BP > 76 mmHG; pulse rate >
82 bpm; glycosylated hemoglobin > 5.7%; BMI > 30.6; HDL cholesterol < 42 mg/dL; total cholesterol >
216 mg/dL; serum albumin < 4.1 g/dL; CRP > 0.37 mg/dL. Previous research indicates these cutoffs as
the preferred method of calculating the components of AL [28,34,35]. To calculate total AL score, one
point was assigned for each high-risk biomarker value, with a total possible score of 9. In accordance
with the literature [10], we consider AL scores of 4 or higher as “high-risk”.
Healthcare 2018, 6, 105 4 of 11
2.5. Covariates
In consideration of potential over-controlling for mediating variables, we strictly limited the
covariates for which we adjusted [36]. We included age, family poverty-to-income ratio (PIR), and
each biomarker as covariates in our primary analysis based on prior literature showing associations
of age and socioeconomic status (SES) with both depression [22] and allostatic load [33]. Age was
stratified into five groups (18–24, 25–34, 35–44, 45–54, and 55–64 years) across which AL is known
to vary [22]. PIR is an index for the ratio of household income to the federal poverty level based on
family size and state of residence. NHANES provides PIR for each participant [26]. We stratified our
analysis into five categories of PIR—“At or below”, “>1 and ≤2×”, “>2 and ≤3×”, “>3 and ≤4×”,
and “>4×” the federal poverty threshold—to better capture the distribution of the biomarkers and
depression across socioeconomic status.
2.6. Statistical Analysis
Statistical analysis was conducted between 1 August 2016 and 15 October 2016. All analyses
were weighted to represent black and white women and men nationally following National Center
for Health Statistics guidelines. For univariate analyses, means or frequencies (%) were reported;
Pearson’s chi-square was used to test for statistically significant differences of categorical variables.
Four multivariable logistic models with a significance level of α = 0.05 estimated the odds of depression
as a function of each biomarker stratified by gendered race, adjusting for age, PIR, and all other
biomarkers. All analyses were conducted using STATA version 14 (StataCorp LLC, College Station,
TX, USA); code is available in Supplementary Materials (Supplementary S1) [37].
3. Results
Exclusions resulted in an analytic sample of 6431 US adults, which represents approximately 113
million black and white women and men nationally. Sociodemographics, depression, and high-risk
levels of each of the nine included biomarkers are reported in Table 1 by gendered race. Black persons
were more likely to be hypertensive and women had higher pulse rates. Half of black women were
obese, while the prevalence of obesity ranged from 30% to 34% in the other three groups. A greater
percentage of black women also had low serum album (52%) and elevated CRP (45%) levels. At 35%,
the prevalence of high levels of glyco-hemoglobin was highest among black men. White men had the
highest prevalence of high total cholesterol (44%) and low HDL cholesterol (39%). With the exception
of low HDL cholesterol, white women had the lowest prevalence of high-risk biomarker levels of all
groups. Black persons and women were more likely to report elevated depressive symptoms.
The adjusted odds of depression associated with high-risk levels of each biomarker is reported
in Table 2 stratified by gendered race. Adjusting for age, socioeconomic status, and all other
biomarkers, high-risk CRP, serum album, and total cholesterol levels, as well as high-risk pulse
rate were differentially associated with increased risk for depression across the four groups. High-risk
CRP levels increased odds of depression among white women (aOR = 1.7, 95% CI: 1.1–2.6) and white
men (aOR = 1.8, 95% CI: 1.1–2.8), while no statistically significant associations were found among black
women (aOR = 0.8, 95% CI: 0.6–1.1) or black men (aOR = 0.9, 95% CI: 0.5–1.5). Similarly, adjusted odds
ratios for high-risk pulse rates were 1.5 (95% CI: 1.1–2.2) and 1.8 (95% CI: 1.1–2.9) for white women
and white men, respectively, but not statistically significant among black women (1.1, 95% CI: 0.7–1.6)
or men (1.2, 95% CI: 0.6–2.4). Among black men only, high-risk levels of systolic BP (aOR = 1.7, 95% CI:
1.1–2.7) and serum albumin (aOR = 1.7, 95% CI: 1.0–2.9) predicted depression. High levels of total
cholesterol were associated with depression among black women (aOR = 1.6, 95% CI: 1.0–2.7).
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Table 1. Sample characteristics by gendered race in NHANES 2005–2010, weighted %.
Measures Black Women White Women Black Men White Men P d
Sample N 980 2147 1028 2276
Weighted N 7,895,277 48,156,035 7,129,498 49,990,472
Age, mean (SD) 40.7 (14.4) 41.7 (13.2) 40.2 (14.8) 41.4 (13.5)
Family PIR a <0.001
≤1 25.3 10.7 19.6 8.3
>1 and ≤2× 25.5 14.0 25.8 13.6
>2 and ≤3× 15.6 13.4 18.4 13.9
>3 and ≤4× 13.4 15.4 14.0 14.8
>4 20.2 46.4 22.1 49.4
High-risk AL
Biomarkers b
Systolic BP 46.5 33.7 48.3 42.3 <0.001
Diastolic BP 50.3 40.4 50.7 50.2 <0.001
Pulse 25.9 24.0 13.5 16.0 <0.001
BMI 50.1 31.4 34.8 30.2 <0.001
Total cholesterol 36.4 43.7 36.3 44.4 <0.001
HDL cholesterol 12.5 14.3 27.3 39.3 <0.001
Glyco-hemoglobin 29.3 14.6 35.4 14.8 <0.001
Serum Albumin 52.4 29.8 23.1 10.5 <0.001
CRP 44.7 32.0 26.2 18.6 <0.001
High-risk AL 17.1 15.3 10.1 7.4 <0.001
Depression c 14.6 8.6 7.1 4.9 <0.001
Abbreviations: AL = allostatic load; BP = blood pressure; BMI = body mass index; HDL = high-density lipoprotein;
CRP = c-reactive protein; PIR = poverty-to-income ratio; a PIR is a ratio of household income to the US poverty
threshold based on family size and state of residence; b “High-risk” thresholds for each biomarker were: systolic BP
> 127.3 mmHG; diastolic BP > 76 mmHG; pulse rate > 82 bpm; glycosylated hemoglobin > 5.7%; BMI > 30.6; HDL
cholesterol < 42 mg/dL; total cholesterol > 216 mg/dL; serum albumin < 4.1 g/dL; and CRP > 0.37 mg/dL; c PHQ-9
scores of ≥10; d p-value from Pearson’s chi-square test.
Table 2. Adjusted a odds of depression b with high-risk allostatic load and biomarker levels by
gendered race in NHANES 2005–2010, OR (95% CI) c.
Biomarker Black Women White Women Black Men White Men
Systolic BP 1.2 (0.6, 2.5) 1.1 (0.6, 2.0) 1.7 (1.1, 2.7) * 1.4 (0.8, 2.5)
Diastolic BP 1.1 (0.6, 2.1) 1.3 (0.8, 2.2) 1.2 (0.8, 1.9) 1.3 (0.8, 2.1)
Pulse 1.1 (0.7, 1.6) 1.5 (1.1, 2.2) * 1.2 (0.6, 2.4) 1.8 (1.1, 2.9) *
BMI 0.8 (0.5, 1.2) 1.1 (0.7, 1.7) 1.1 (0.6, 2.0) 0.9 (0.6, 1.3)
Total cholesterol 1.6 (1.0, 2.7) * 1.1 (0.8, 1.5) 1.0 (0.5, 2.0) 0.8 (0.4, 1.3)
HDL cholesterol 1.2 (0.6, 2.3) 1.1 (0.7, 1.7) 1.7 (0.9, 3.4) 1.3 (0.8, 1.9)
Glyco-hemoglobin 1.1 (0.8, 1.7) 1.0 (0.6, 1.7) 0.9 (0.5, 1.6) 0.8 (0.5, 1.4)
Serum Albumin 0.9 (0.6, 1.3) 1.0 (0.7, 1.6) 1.7 (1.0, 2.9) * 1.3 (0.7, 2.5)
CRP 0.8 (0.6, 1.1) 1.7 (1.1, 2.6) * 0.9 (0.5, 1.5) 1.8 (1.1, 2.8) *
High-risk AL d 1.1 (0.6, 2.0) 2.1 (1.5, 3.0) * 1.7 (1.0, 2.9) * 1.4 (0.8, 2.5)
Abbreviations: BP = blood pressure; BMI = body mass index; HDL = high-density lipoprotein; CRP = c-reactive
protein; a models adjusted for PIR (ratio of household income to the US poverty threshold), age, and all biomarkers;
b PHQ-9 scores of ≥10; c results are from four separate regression models. The reference category for the biomarkers
in each model is “low-risk”; d AL scores of ≥4 were considered “high-risk”.
4. Discussion
Our results support the differential effect hypothesis. The relationship between a number of
physiological markers of chronic stress and depressive symptoms varied with respect to gendered race.
While the prevalence of depression and high-risk inflammation indicators were notably higher among
black women than white women, black men, or white men, black women were the only of the four
Healthcare 2018, 6, 105 6 of 11
groups among whom inflammation was not associated with depression. The biomarkers associated
with depression were also consistent among white women and men, but not among black persons.
Adverse levels of serum album and systolic BP predicted depression in black men, while among black
women, high-risk levels of total cholesterol were associated with depression.
4.1. Gendered Racial Variation in Manifestations of Chronic Stress
An extensive body of literature supports gender and racial differences in the prevalence of
inflammation [37–41], as well as in the cardiovascular and metabolic biomarkers comprising the
allostatic load [13,18–20]. Our findings are consistent with prior literature showing that the prevalence
of elevated pulse rate and inflammation tends to be higher among women regardless of race [13,42].
Even accounting for socioeconomic position, black women are particularly susceptible to premature
aging, chronic inflammation, and associated conditions such as obesity [10,20,33], results that are
supported in this analysis. In line with extant research, we also found high levels of total cholesterol
and low levels of HDL cholesterol to be more prevalent among men and white persons [43].
Data linking adverse social exposures to increased risk of inflammation and subsequently
depression [13,43] provide some support for the differential effect hypothesis but fall short of
accounting for the concomitant effects of gender and race on the experience of social stimuli and
for how this interaction influences variability in risk for psychiatric disorder. In contrast, research
grounded in intersectionality theory has identified gendered racial differences in the effects of stress
on mental health, finding a stronger association between stressful life events and major depressive
episodes among white men than black men while identifying no such interaction among women [44].
Another study examined how allostatic load differentially predicts depressive symptoms in black
and white women and men, finding an association only among black men and white women [45]. In
accordance with these findings, our results indicate different underlying disease relationships among
black and white women and men, divergence in the predictors of depressive symptoms potentially
steered by unmeasured psychosocial exposures that are unique to each gendered race. Such variability
in the experience of stress and its psychiatric presentation may indicate the necessity for more nuanced
approaches to patient evaluation and prescribing practices.
4.2. Divergence in the Pathways from Chronic Stress to Depression
As noted earlier, treatment efficacy among black and white women and men contributes to
disparities in morbidity [6] and is likely complicated by differences in the neurobiological processes
associated with depression between these groups. In this study, inflammatory markers predicted
depression in all groups except black women. Specifically, CRP, elevated levels of which have been
increasingly identified as a risk factor for depression [13,18], was associated with increased odds
only among whites. Previous findings [27,28] have identified an association of CRP with depressive
symptoms only among whites and not blacks. Our study further builds on this evidence by identifying
within-race gender differences in the association of inflammation with depression, as well as in other
gendered race group-specific markers of chronic stress predictive of depression which have been
earlier noted in the literature [46]. These findings are of particular interest in light of other literature
demonstrating symptom-specific associations of CRP with depression. In one study, investigators
found that higher levels of inflammation are more likely to underlie depressive symptoms indicative
of sickness behavior including fatigue, reduced appetite, withdrawal, and inhibited motivation [29].
As black persons are more likely to report these somatic symptoms, our findings stand in contrast to
this evidence, providing further indication of distinct physiological pathways from stress associated
with social inequity to the development of depression among black and white women and men.
These disparate relationships suggest that, while a genetic predisposition may contribute to
the likelihood of developing risk factors for depression such as inflammation [42], the particular
experience of the social environment that is predicated upon one’s gendered race plays an integral
part in depression pathogenesis [47]. This assertion is consistent with evidence for an interactive effect
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of genotype and social context on depression that varies with gender [15]. Such social environmental
exposures moderating the experience of stress and subsequent effects on mental health may include
cultural influences on racially informed gender roles and expectations, as well as the frequency and
severity of perceived prejudice [47–50].
Research suggests that white women are more likely to ruminate and self-blame following identity
threat (e.g., following discrimination exposure) than black women or white men [4,47–51], a socialized
stress response [49] that may contribute to a greater proclivity for affective symptoms of depression
under certain kinds of chronic stress [48]. In contrast, coping with the co-occurrence of racial and
gender identity-based stressors may have allowed for the development of a psychological fortitude that
is protective against depression, or affective symptoms of depression, under these conditions among
black women [52,53], despite greater exposure to genetic and psychosocial risk factors for inflammation.
The chronic strain-inflammation pathway of depression may therefore be more applicable to those
operating within sociocultural paradigms that yield psychological and behavioral responses to social
status-based stress—responses that may in turn exacerbate biological vulnerability to depression.
Given potentially diverging mechanisms, approaches to evaluating and developing treatment plans
for patients presenting with depressive symptoms should consider the sociocultural factors associated
with gendered race as drivers of differences in underlying disease causes.
4.3. Limitations
This study has important limitations requiring acknowledgement. While the PHQ-9 has been
validated and shown to have strong reliability and validity within a range of racial and ethnic
populations [53], and among women and men [54], the instrument assesses depression based on
current symptoms. Depressed individuals being successfully treated with medication or therapy
may not be captured by the PHQ-9. Accordingly, our estimates of the association between allostatic
load biomarkers and depression may be underestimated, particularly among white women, who are
most likely of the groups under study to seek and undergo treatment for depression [55–58]. Our
analysis was limited to NHANES 2005–2010 because the 2005–2006 surveys were the first to include
the PHQ-9, and 2009–2010 was the latest wave to include all nine biomarkers used to calculate AL.
This limited sample size prevented further analysis of interactive effects within stratified models.
Research examining these associations among larger and more contemporary cohorts of US adults is
therefore needed.
The number of participants excluded for missing data could raise concern about the
representativeness of our sample. However, among those excluded due to missing data on biomarkers,
missingness was distributed independently such that excluding one biomarker would not recover
a significant number of respondents. Similarly, family PIR missingness was approximately equally
distributed across AL biomarkers, race, and gender. Among participants missing depression scores,
approximately 24% were black and 36% white. This missingness by race was distributed approximately
equally across men and women, although not across income categories; participants excluded for
missing information on depression had lower family PIRs (data are not shown).
5. Conclusions
Our findings provide some evidence of fundamental differences in the underlying neurological
processes leading to depression pathogenesis among US black and white women and men. Interventions
designed to eradicate social inequities remain important to reduce racial and gender disparities in a
number of chronic diseases. However, implementing such interventions are challenging due in part to
sociopolitical barriers and a lack of consensus among policy makers for best practices. Additional
approaches at the individual level may complement system-level efforts by targeting the specific
pathways over which chronic, identity-based, psychosocial stressors act to cause depression in different
sociodemographic groups. On the importance of causal frameworks in the treatment of psychiatric
disorders, Aaron Lazare opined: “The complexity of the decision-making process resulting from the
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use of several models may unnecessarily limit the treatment options of the psychiatrist [ . . . ] If the
conceptual models and their use in clinical psychiatry are made explicit, a broader range of treatment
modalities should be made available” [59].
This study raises important concerns about the efficacy of psychiatric treatments which neglect
sociocultural influences on the presentation of both chronic stress and depressive symptoms. Refining
drug and psychotherapies as appropriate for distinct depression etiologies may yield improved
treatment outcomes and reduce disparities between black and white women and men. We also
suggest that prevention efforts should further focus on building resilience that targets the specific
vulnerabilities associated with an individual’s gendered race. Additional research exploring the
psychosocial and cultural exposures that contribute to the varied manifestations of chronic stress and
depression would significantly strengthen subsequent research investigating the nature of gendered
racial differences in depression etiology.
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